Founder, atai Life Sciences
Christian Angermayer is an entrepreneur, investor and film enthusiast. He is the founder of Apeiron Investment Group, his family office and merchant banking business. Apeiron focuses on Financial Services (especially fintech and crypto assets), Technology, Life Sciences, Media & Entertainment and Real Estate. Apeiron completes deals across the entire lifecycle and balance sheet of a company, from non-listed Seed/Start Up investments to larger scale Restructuring and Special Situations deals (mostly listed).
Passionate about the arts and film, Christian has (executive) produced 14 feature films including critically acclaimed movies like Filth, Aspern Papers and Hector and the Search for Happiness. He is the largest shareholder of DEAG, one of the largest live entertainment companies in Europe, producing over 4.500 shows per year from pop to classic and from exhibitions to family entertainment. Christian has a unique art collection centered around the theme “Psychedelics / Entheogens”.
In 2000, Christian co-founded Ribopharma (original patents for RNAi technology) which merged with US peer Alnylam in 2003 and subsequently went public. Since then, Christian has created, co-founded and invested in numerous successful companies, has raised approx. USD 2bn for his portfolio companies and has been involved in more than 40 successful IPO- and M&A-transactions either as an entrepreneur, investor or banker/advisor. UK Newspaper Sunday Times ranks Christian in its May 2019 special wealth report among the 1,000 richest people living in the United Kingdom with an estimated net worth of approx. USD 400 million.
With his biotech company atai Life Sciences, Christian has the ambitious goal to enable people to live healthier and happier lives. atai’s focus is on developing solutions for the more than 300 million people who suffer from depression, especially by bringing back formerly vilified drugs like psychedelics into the legal realm.